You have 9 free searches left this month | for more free features.

tegavivint

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Mar 21, 2023

Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)

Recruiting
  • Recurrent Leukemia
  • Refractory Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Columbus

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 14, 2022

Recurrent DLBCL Activated B-Cell Type, Recurrent DLBCL Germinal Center B-Cell Type, Recurrent High Grade B-Cell Lymphoma With

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • +8 more
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 8, 2023

Desmoid Tumor Trial in Canada, United States (Tegavivint)

Completed
  • Desmoid Tumor
  • Tegavivint
  • Boston, Massachusetts
  • +6 more
Jun 8, 2022

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023